A significant breakthrough in cancer study is arising with the use of VHH fragments to re-engage mutated p53. This vital cancer suppressor protein is frequently inactivated in various types of malignancies, resulting https://bookmarkingfeed.com/story21835412/mini-antibodies-reactivate-tumor-suppressor-p53-new-promising-hope-for-tumor-treatment